The science
The pharmacology of topical L-ascorbic acid is unusually well characterised. Percutaneous absorption requires the protonated form, which depends on a formulation pH below about 3.5, and uptake increases with concentration up to approximately 20%, beyond which tissue levels plateau while irritation continues to rise — the dose-response established in the foundational work on vitamin C delivery that underlies every serious ascorbic serum. At 27% and first on the list, this ampoule sits above that plateau; tromethamine is used as a buffer to raise the pH toward tolerability, which trades some absorption for comfort. Once in the skin, ascorbic acid inhibits tyrosinase, reduces oxidised melanin intermediates, scavenges reactive oxygen species and supports collagen synthesis, mechanisms that justify its use for post-inflammatory and photo-induced hyperpigmentation over eight to twelve weeks with photoprotection. L-ascorbic acid in aqueous solution oxidises readily; ferulic acid and tocopherol, both present here, are the documented stabilisers that slow that degradation and extend antioxidant activity, and ethyl ascorbyl ether adds a stable derivative with independent brightening data. Refrigeration and the one-month use window are appropriate responses to the instability of a high-dose aqueous formula.
The formula's liabilities are equally documented. Citrus bergamia fruit oil contains bergapten (5-methoxypsoralen), a furocoumarin that absorbs UVA and produces phototoxic reactions and post-inflammatory pigmentation; expressed lemon and bitter/sweet orange peel oils carry related furocoumarins, and lavender and ylang-ylang oils contribute linalool and other terpenes that rank among the more frequent fragrance allergens in patch-test series. Their inclusion in a night-only pigment serum is managed by usage instructions rather than removed by formulation, and represents a genuine risk for photosensitive, rosacea-prone and melasma-prone skin, where irritation and heat are known drivers of pigment. Centella asiatica extract, madecassoside, panthenol, allantoin, beta-glucan and dipotassium glycyrrhizate have anti-inflammatory and barrier-supporting evidence that partially offsets the acidity. Niacinamide, glutathione and glucosylrutin contribute secondary antioxidant and pigment-transfer effects at supporting levels. Goodal's 7-day brightening claim and 'dermatologically tested' statement derive from in-house testing; no independent clinical study of the ampoule exists.